API Holdings updates pledge release disclosure for Thyrocare shares
NiveshIQ
NSE: THYROCARE · IT
Thyrocare Technologies Ltd.
₹549.70▼ ₹8.00 (-1.43%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on THYROCARE. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Thyrocare Technologies Ltd.
Thyrocare Technologies Limited is a leading diagnostic testing services provider in India, operating through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company offers a range of diagnostic and pathological services, including pathology testing, imaging services, and glucometer sales under the brand name Sugarscan. With a strong presence in the Indian healthcare market, Thyrocare has reported revenue of ₹876 Cr and net income of ₹176 Cr. The company's recent Q1FY27 results showed a 24% YoY growth in revenue to ₹240.02 Cr, indicating a robust performance. Thyrocare's competitive position is strengthened by its extensive network of laboratories and hospitals, as well as its focus on quality and customer service. The company's growth outlook is positive, dri
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹572.00 Cr +116.70% | ₹687.00 Cr +20.10% | ₹829.95 Cr +20.80% |
| EBITDA Margin | 24.30% | 27.51% | 32.10% |
| Net Profit | ₹69.00 Cr +155.60% | ₹91.00 Cr +31.90% | ₹162.70 Cr +78.80% |
| EPS | ₹4.46 | ₹5.76 | ₹10.28 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Thyrocare Technologies: Promoter API Holdings Fully Redeems Debt, Releases All Pledges
Thyrocare Technologies: प्रमोटर्सचे मोठे पाऊल! कर्जाची परतफेड करत शेअर्सचा गळफास सोडवला
🔒
+ 3 more stories about Thyrocare Technologies Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹240 Cr, PAT ₹51 Cr, EPS ₹3.23, EBITDA margin 33.9%. Growth context: revenue QoQ +7.2%, PAT QoQ +5.4%. Street verdict: miss, revenue surprise +5.2%, PAT surprise -43.6%.
Test volumes, test mix, B2B/reference-lab traction, pricing discipline, and operating leverage are expected to remain ke...
FY26 (last completed FY): revenue ₹830 Cr, PAT ₹163 Cr, EBITDA margin 32.1%, EPS ₹10.28. Year-on-year: revenue YoY +20.8...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for THYROCARE
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track THYROCARE alongside your other holdings
Unlock full THYROCARE research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Thyrocare Technologies Ltd.?
NiveshIQ detects active intelligence signals for Thyrocare Technologies Ltd. (THYROCARE) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Thyrocare Technologies Ltd.?
Thyrocare Technologies Ltd. operates in the IT sector with a market capitalisation of ₹773,525.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.